An Italian biotech gets $52M to advance pediatric gene therapies
Genespire, an Italy-based biotechnology startup making “off-the-shelf” gene therapies treatment for rare pediatric genetic conditions, has raised €46.6 million euros, or about $52 million, in a Series B round announced Wednesday. The capital infusion will …